UK's medicine regulator said on Monday it has temporarily restricted the use of French vaccine maker Valneva's shot to treat ...

Dr. Harindu Wijesinghe is a medical specialist in Rheumatology and Rehabilitation, as well as in Sports Medicine. He ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Bavarian Nordic has commenced a Phase III trial of its chikungunya vaccine, CHIKV VLP, targeting the paediatric population ...

Paris: Health authorities in France have confirmed the first locally transmitted case of mosquito-borne chikungunya this year ...

France confirms its first locally transmitted chikungunya case of 2025 in La Crau, Var, as health officials ramp up mosquito control efforts.

A landmark global modeling study reveals that more than 2.8 billion people in 104 countries are at risk of chikungunya, with ...

Women appear more susceptible to chikungunya, with 58.6% of reported cases affecting females, compared to 42.6% among males, ...

First children vaccinated in clinical study seeking to expand the target population for the chikungunya vaccine. COPENHAGEN, ...

Results from the Phase II VLA1553-221 trial show that a full dose of Ixchiq demonstrated a 96.5% seroresponse rate in ...

Health authorities in France have confirmed the first locally transmitted case of mosquito-borne chikungunya this year.The R ...

Valneva has reported encouraging six-month safety and antibody persistence data from the multi-centre Phase II trial, VLA1553 ...